GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:22012064

From GONUTS
Jump to: navigation, search
Citation

Huang, G, Zhao, X, Wang, L, Elf, S, Xu, H, Zhao, X, Sashida, G, Zhang, Y, Liu, Y, Lee, J, Menendez, S, Yang, Y, Yan, X, Zhang, P, Tenen, DG, Osato, M, Hsieh, JJ and Nimer, SD (2011) The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations. Blood 118:6544-52

Abstract

The mixed-lineage leukemia (MLL) H3K4 methyltransferase protein, and the heterodimeric RUNX1/CBFβ transcription factor complex, are critical for definitive and adult hematopoiesis, and both are frequently targeted in human acute leukemia. We identified a physical and functional interaction between RUNX1 (AML1) and MLL and show that both are required to maintain the histone lysine 4 trimethyl mark (H3K4me3) at 2 critical regulatory regions of the AML1 target gene PU.1. Similar to CBFβ, we show that MLL binds to AML1 abrogating its proteasome-dependent degradation. Furthermore, a subset of previously uncharacterized frame-shift and missense mutations at the N terminus of AML1, found in MDS and AML patients, impairs its interaction with MLL, resulting in loss of the H3K4me3 mark within PU.1 regulatory regions, and decreased PU.1 expression. The interaction between MLL and AML1 provides a mechanism for the sequence-specific binding of MLL to DNA, and identifies RUNX1 target genes as potential effectors of MLL function.

Links

PubMed PMC3242717 Online version:10.1182/blood-2010-11-317909

Keywords

Acute Disease; Blotting, Western; Cell Line; Cell Line, Tumor; Chromatin Immunoprecipitation; Core Binding Factor Alpha 2 Subunit/genetics; Core Binding Factor Alpha 2 Subunit/metabolism; Core Binding Factor beta Subunit/genetics; Core Binding Factor beta Subunit/metabolism; Gene Expression; HEK293 Cells; Histone-Lysine N-Methyltransferase; Histones/metabolism; Humans; Leukemia, Myeloid/genetics; Leukemia, Myeloid/metabolism; Leukemia, Myeloid/pathology; Lysine/metabolism; Methylation; Mutation; Myelodysplastic Syndromes/genetics; Myelodysplastic Syndromes/metabolism; Myelodysplastic Syndromes/pathology; Myeloid-Lymphoid Leukemia Protein/genetics; Myeloid-Lymphoid Leukemia Protein/metabolism; Protein Binding; Proto-Oncogene Proteins/genetics; Proto-Oncogene Proteins/metabolism; Regulatory Sequences, Nucleic Acid/genetics; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators/genetics; Trans-Activators/metabolism

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

HUMAN:KMT2A

enables

GO:0042800: histone methyltransferase activity (H3-K4 specific)

ECO:0000269: experimental evidence used in manual assertion

F

Seeded From UniProt

complete

Notes

See also

References

See Help:References for how to manage references in GONUTS.